Jennifer Harthan
About
In The Last Decade
Jennifer Harthan
35 papers receiving 487 citations
Peers
Comparison fields: 5 of 44
- Public Health, Environmental and Occupational Health 378
- Radiology, Nuclear Medicine and Imaging 291
- Ophthalmology 175
- Epidemiology 117
- Dermatology 112
Countries citing papers authored by Jennifer Harthan
This map shows the geographic impact of Jennifer Harthan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Harthan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Harthan more than expected).
Fields of papers citing papers by Jennifer Harthan
This network shows the impact of papers produced by Jennifer Harthan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Harthan. The network helps show where Jennifer Harthan may publish in the future.
Co-authorship network of co-authors of Jennifer Harthan
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Harthan. A scholar is included among the top collaborators of Jennifer Harthan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Harthan. Jennifer Harthan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 12 | |
| 8 | 11 | |
| 9 | 2 | |
| 10 | 27 | |
| 11 | Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis | 2 |
| 12 | Reducing Adenoviral Patient Infected Days (RAPID) Study: Success in Masking Subjects and Clinicians From Identifying Treatment with Ophthalmic Povidone-Iodine 5% (PVP-I). | 1 |
| 13 | 36 | |
| 14 | 92 | |
| 15 | 40 | |
| 16 | Reducing Adenoviral Patient Infected Days (RAPID) Study: Association of Clinical Signs and Symptoms with qPCR confirmed Adenoviral Conjunctivitis | 1 |
| 17 | 45 | |
| 18 | 35 | |
| 19 | Complications of Scleral Lens Wear | 1 |
| 20 | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.